Katrine M Johannesen1,2, Natalya Nikanorova1, Dragan Marjanovic3, Agnieszka Pavbro3, Line H G Larsen4, Guido Rubboli1,5, Rikke S Møller1,2. 1. Department of Epilepsy Genetics and Personalized Treatment, Danish Epilepsy Center, Dianalund, Denmark. 2. Department of Regional Health Research, University of Southern Denmark, Odense, Denmark. 3. Department of Neurology, Danish Epilepsy Center, Dianalund, Denmark. 4. Amplexa Genetics, Odense, Denmark. 5. University of Copenhagen, Copenhagen, Denmark.
Abstract
OBJECTIVE: Genetic testing has become a routine part of the diagnostic workup in children with early onset epilepsies. In the present study, we sought to investigate a cohort of adult patients with epilepsy, to determinate the diagnostic yield and explore the gain of personalized treatment approaches in adult patients. METHODS: Two hundred patients (age span = 18-80 years) referred for diagnostic gene panel testing at the Danish Epilepsy Center were included. The vast majority (91%) suffered from comorbid intellectual disability. The medical records of genetically diagnosed patients were mined for data on epilepsy syndrome, cognition, treatment changes, and seizure outcome following the genetic diagnosis. RESULTS: We found a genetic diagnosis in 46 of 200 (23%) patients. SCN1A, KCNT1, and STXBP1 accounted for the greatest number of positive findings (48%). More rare genetic findings included SLC2A1, ATP6A1V, HNRNPU, MEF2C, and IRF2BPL. Gene-specific treatment changes were initiated in 11 of 46 (17%) patients (one with SLC2A1, 10 with SCN1A) following the genetic diagnosis. Ten patients improved, with seizure reduction and/or increased alertness and general well-being. SIGNIFICANCE: With this study, we show that routine diagnostic testing is highly relevant in adults with epilepsy. The diagnostic yield is similar to previously reported pediatric cohorts, and the genetic findings can be useful for therapeutic decision-making, which may lead to better seizure control, ultimately improving quality of life.
OBJECTIVE: Genetic testing has become a routine part of the diagnostic workup in children with early onset epilepsies. In the present study, we sought to investigate a cohort of adult patients with epilepsy, to determinate the diagnostic yield and explore the gain of personalized treatment approaches in adult patients. METHODS: Two hundred patients (age span = 18-80 years) referred for diagnostic gene panel testing at the Danish Epilepsy Center were included. The vast majority (91%) suffered from comorbid intellectual disability. The medical records of genetically diagnosed patients were mined for data on epilepsy syndrome, cognition, treatment changes, and seizure outcome following the genetic diagnosis. RESULTS: We found a genetic diagnosis in 46 of 200 (23%) patients. SCN1A, KCNT1, and STXBP1 accounted for the greatest number of positive findings (48%). More rare genetic findings included SLC2A1, ATP6A1V, HNRNPU, MEF2C, and IRF2BPL. Gene-specific treatment changes were initiated in 11 of 46 (17%) patients (one with SLC2A1, 10 with SCN1A) following the genetic diagnosis. Ten patients improved, with seizure reduction and/or increased alertness and general well-being. SIGNIFICANCE: With this study, we show that routine diagnostic testing is highly relevant in adults with epilepsy. The diagnostic yield is similar to previously reported pediatric cohorts, and the genetic findings can be useful for therapeutic decision-making, which may lead to better seizure control, ultimately improving quality of life.
Authors: Andreas Brunklaus; Eduardo Pérez-Palma; Ismael Ghanty; Ji Xinge; Eva Brilstra; Berten Ceulemans; Nicole Chemaly; Iris de Lange; Christel Depienne; Renzo Guerrini; Davide Mei; Rikke S Møller; Rima Nabbout; Brigid M Regan; Amy L Schneider; Ingrid E Scheffer; An-Sofie Schoonjans; Joseph D Symonds; Sarah Weckhuysen; Michael W Kattan; Sameer M Zuberi; Dennis Lal Journal: Neurology Date: 2022-01-24 Impact factor: 11.800
Authors: Madelyn A Gillentine; Tianyun Wang; Kendra Hoekzema; Jill Rosenfeld; Pengfei Liu; Hui Guo; Chang N Kim; Bert B A De Vries; Lisenka E L M Vissers; Magnus Nordenskjold; Malin Kvarnung; Anna Lindstrand; Ann Nordgren; Jozef Gecz; Maria Iascone; Anna Cereda; Agnese Scatigno; Silvia Maitz; Ginevra Zanni; Enrico Bertini; Christiane Zweier; Sarah Schuhmann; Antje Wiesener; Micah Pepper; Heena Panjwani; Erin Torti; Farida Abid; Irina Anselm; Siddharth Srivastava; Paldeep Atwal; Carlos A Bacino; Gifty Bhat; Katherine Cobian; Lynne M Bird; Jennifer Friedman; Meredith S Wright; Bert Callewaert; Florence Petit; Sophie Mathieu; Alexandra Afenjar; Celenie K Christensen; Kerry M White; Orly Elpeleg; Itai Berger; Edward J Espineli; Christina Fagerberg; Charlotte Brasch-Andersen; Lars Kjærsgaard Hansen; Timothy Feyma; Susan Hughes; Isabelle Thiffault; Bonnie Sullivan; Shuang Yan; Kory Keller; Boris Keren; Cyril Mignot; Frank Kooy; Marije Meuwissen; Alice Basinger; Mary Kukolich; Meredith Philips; Lucia Ortega; Margaret Drummond-Borg; Mathilde Lauridsen; Kristina Sorensen; Anna Lehman; Elena Lopez-Rangel; Paul Levy; Davor Lessel; Timothy Lotze; Suneeta Madan-Khetarpal; Jessica Sebastian; Jodie Vento; Divya Vats; L Manace Benman; Shane Mckee; Ghayda M Mirzaa; Candace Muss; John Pappas; Hilde Peeters; Corrado Romano; Maurizio Elia; Ornella Galesi; Marleen E H Simon; Koen L I van Gassen; Kara Simpson; Robert Stratton; Sabeen Syed; Julien Thevenon; Irene Valenzuela Palafoll; Antonio Vitobello; Marie Bournez; Laurence Faivre; Kun Xia; Rachel K Earl; Tomasz Nowakowski; Raphael A Bernier; Evan E Eichler Journal: Genome Med Date: 2021-04-19 Impact factor: 11.117
Authors: Elena Valeryevna Feofanova; Guo-Qiang Zhang; Samden Lhatoo; Ginger A Metcalf; Eric Boerwinkle; Eric Venner Journal: JMIR Res Protoc Date: 2021-03-26
Authors: Pia Zacher; Thomas Mayer; Frank Brandhoff; Tobias Bartolomaeus; Diana Le Duc; Martin Finzel; Anja Heinze; Susanne Horn; Chiara Klöckner; Gudrun Körber; Julia Hentschel; Malgorzata Kalita; Ilona Krey; Marina Nastainczyk-Wulf; Konrad Platzer; Johannes Rebstock; Bernt Popp; Mathias Stiller; Anne-Christin Teichmann; Rami Abou Jamra; Johannes R Lemke Journal: Genet Med Date: 2021-04-28 Impact factor: 8.822
Authors: Paul C Marcogliese; Debdeep Dutta; Shrestha Sinha Ray; Nghi D P Dang; Zhongyuan Zuo; Yuchun Wang; Di Lu; Fatima Fazal; Thomas A Ravenscroft; Hyunglok Chung; Oguz Kanca; JiJun Wan; Emilie D Douine; Undiagnosed Diseases Network; Loren D M Pena; Shinya Yamamoto; Stanley F Nelson; Matthew Might; Kathrin C Meyer; Nan Cher Yeo; Hugo J Bellen Journal: Sci Adv Date: 2022-01-19 Impact factor: 14.136